1-3 of 3
Markus Roeßler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors

Didier Meulendijks, Ulrik N. Lassen, Lillian L. Siu, Alwin D.R. Huitema, Vaios Karanikas, Morten Mau-Sorensen, Derek J. Jonker, Aaron R. Hansen, Mary E. Simcox, Kathleen J. Schostack, Dean Bottino, Hua Zhong, Markus Roessler, Suzana M. Vega-Harring, Tiantom Jarutat, David Geho, Karen Wang, Mark DeMario, Glenwood D. Goss, Jan H.M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (4): 858–867.
https://doi.org/10.1158/1078-0432.CCR-15-1506
Published: 14 February 2016
View article titled, Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors
Open the PDF for Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors in another window
Journal Articles

A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

Ulrik N. Lassen, Didier Meulendijks, Lilian L. Siu, Vaios Karanikas, Morten Mau-Sorensen, Jan H.M. Schellens, Derek J. Jonker, Aaron R. Hansen, Mary E. Simcox, Kathleen J. Schostack, Dean Bottino, Hua Zhong, Markus Roessler, Suzana M. Vega-Harring, Tiantom Jarutat, David Geho, Ka Wang, Mark DeMario, Glenwood D. Goss
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 258–266.
https://doi.org/10.1158/1078-0432.CCR-14-1334
Published: 14 January 2015
View article titled, A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers
Open the PDF for A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers in another window
Includes: Supplementary data
Journal Articles

Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer

Markus Roeßler, Wolfgang Rollinger, Stefan Palme, Marie-Luise Hagmann, Peter Berndt, Alfred M. Engel, Bernd Schneidinger, Michael Pfeffer, Herbert Andres, Johann Karl, Heinz Bodenmüller, Josef Rüschoff, Thomas Henkel, Gerhard Rohr, Siegbert Rossol, Wolfgang Rösch, Hanno Langen, Werner Zolg, Michael Tacke
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6550–6557.
https://doi.org/10.1158/1078-0432.CCR-05-0983
Published: 15 September 2005
View article titled, Identification of Nicotinamide <em>N</em>-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer
Open the PDF for Identification of Nicotinamide <em>N</em>-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer in another window
Includes: Supplementary data